China–Switzerland FTA – Origin Cumulation Pharmaceutical Products

Quelle: https://www.eda.admin.ch/aboutswitzerland/en/home/foreign-policy/economy/fta/china.html

A mechanism under the Free Trade Agreement between China and Switzerland that allows the origin rules for pharmaceutical products to be flexibly applied through the cumulation of origin elements from both countries.

Related Terms

You might also be interested in these terms

China–Switzerland FTA

The China–Switzerland FTA is a free trade agreement that facilitates trade between China and Switzerland by reducing tariffs and trade barriers.

Learn more

China-Switzerland FTA – Origin Cumulation Toys

The China-Switzerland Free Trade Agreement allows toys produced in either China or Switzerland to be treated cumulatively under certain conditions, re...

Learn more

CAFTA-DR – Origin Cumulation Pharmaceutical Products

CAFTA-DR – Origin cumulation refers to the mechanism under the Central America Free Trade Agreement – Dominican Republic that allows countries to appl...

Learn more

EFTA–China FTA – Origin Cumulation Pharmaceutical Products

Origin cumulation under the EFTA–China FTA refers to the regulation that allows materials and products from certain EFTA states and China to be aggreg...

Learn more

EFTA–Chile FTA – Origin Cumulation Pharmaceutical Products

The EFTA-Chile Free Trade Agreement allows for origin cumulation for pharmaceutical products, meaning that these products can benefit from the accumul...

Learn more

China-Switzerland FTA – Origin Cumulation Rubber

The origin cumulation under the China-Switzerland Free Trade Agreement allows rubber that has been processed in China or Switzerland to be considered ...

Learn more